Most people start GLP-1 medications for weight loss or blood sugar control. But one of the more surprising benefits showing up in clinical trials is significant improvement in lipid (cholesterol) profiles — even beyond what weight loss alone would explain.
Some of the lipid improvement is due to weight loss — as body fat decreases, so does lipid production in the liver. But GLP-1 receptors are also expressed in the liver and may directly influence fat metabolism and lipoprotein processing, independent of weight changes.
The LEADER trial (liraglutide) and SELECT trial (semaglutide) demonstrated significant reductions in major cardiovascular events — heart attacks, strokes, and cardiovascular deaths — in high-risk populations. Cholesterol improvements are one piece of this larger cardiovascular benefit.
Never stop or adjust cholesterol medication without consulting your doctor. GLP-1 improvements in lipids are meaningful but vary by individual. Your prescriber will monitor your labs and advise on whether medication adjustments are appropriate.
Getting 100g+ of protein daily on a reduced appetite is hard. Strategic timing makes it more achievable — and more effective for muscle preservation.
Medication helps with appetite. But the mental skills for sustainable weight management — resilience, flexibility, self-compassion — must be built intentionally.
People who share their journey with a community — online or in person — consistently achieve better outcomes. Here's why, and where to find yours.